All‐cause mortality maximum · neonates with early‐onset sepsis
It is very uncertain whether ticarcillin plus clavulanic acid changes all‐cause mortality maximum compared with piperacillin plus gentamicin (very low certainty).
1 finding from 1 review
Serious adverse events maximum · neonates with early‐onset sepsis
It is very uncertain whether ticarcillin plus clavulanic acid changes serious adverse events maximum compared with piperacillin plus gentamicin (very low certainty).
1 finding from 1 review
Diagnostic accuracy on surfaces with pit and fissure sealants · Asymptomatic children, adolescents, or adults presenting for clinical examination (in vivo studies), or extracted teeth of children or…
The review found no eligible studies for this question.
1 finding from 1 review
Diagnostic accuracy in previously restored teeth (secondary caries) · Asymptomatic children, adolescents, or adults presenting for clinical examination (in vivo studies), or extracted teeth of children or…
The review found no eligible studies for this question.
1 finding from 1 review
Outcomes at ≥ 3 months · preventing early recurrence after ischaemic stroke or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Deaths due to vascular events · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Myocardial infarction · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in myocardial infarction compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Stroke, myocardial infarction, or vascular death · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke, myocardial infarction, or vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in intracranial haemorrhage compared with one antiplatelet agent (low certainty).
1 finding from 1 review
Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual leads to higher extracranial haemorrhage compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Ischaemic stroke · preventing early recurrence after ischaemic stroke or TIA
Dual leads to lower ischaemic stroke compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Stroke · preventing early recurrence after ischaemic stroke or TIA
Multiple probably leads to lower stroke compared with fewer antiplatelet agents (moderate certainty).
1 finding from 1 review
Deaths due to vascular events · preventing early recurrence after ischaemic stroke or TIA
Multiple showed no clear difference in vascular death compared with fewer antiplatelet agents (moderate certainty).
1 finding from 1 review
Myocardial infarction · preventing early recurrence after ischaemic stroke or TIA
Multiple showed no clear difference in myocardial infarction compared with fewer antiplatelet agents (high certainty).
1 finding from 1 review
Stroke, myocardial infarction, or vascular death · preventing early recurrence after ischaemic stroke or TIA
Multiple probably leads to lower stroke, myocardial infarction, or vascular death compared with fewer antiplatelet agents (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Multiple may leads to higher intracranial haemorrhage compared with fewer antiplatelet agents (low certainty).
1 finding from 1 review
Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Multiple leads to higher extracranial haemorrhage compared with fewer antiplatelet agents (high certainty).
1 finding from 1 review
Ischaemic stroke · preventing early recurrence after ischaemic stroke or TIA
Multiple leads to lower ischaemic stroke compared with fewer antiplatelet agents (high certainty).
1 finding from 1 review
Outcomes at ≥ 3 months · preventing early recurrence after ischaemic stroke or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found